HLB Science (XKRX:343090) Price-to-Tangible-Book : (As of May. 20, 2024)

View and export this data going back to 2020. Start your Free Trial

What is HLB Science Price-to-Tangible-Book?

As of today (2024-05-20), HLB Science's share price is ₩2075.00. HLB Science's Tangible Book per Share of . 20 for the quarter that ended in . 20 was ₩0.00. Hence, HLB Science's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for HLB Science's Price-to-Tangible-Book or its related term are showing as below:

XKRX:343090' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 27.32 Med: 33.71 Max: 33.71
Current: 27.32

During the past 2 years, HLB Science's highest Price to Tangible Book Ratio was 33.71. The lowest was 27.32. And the median was 33.71.

XKRX:343090's Price-to-Tangible-Book is ranked worse than
97.32% of 1230 companies
in the Biotechnology industry
Industry Median: 2.81 vs XKRX:343090: 27.32

A closely related ratio is called PB Ratio. As of today, HLB Science's share price is ₩2075.00. HLB Science's Book Value per Sharefor the quarter that ended in . 20 was ₩0.00. Hence, HLB Science's P/B Ratio of today is .

HLB Science Price-to-Tangible-Book Historical Data

The historical data trend for HLB Science's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Price-to-Tangible-Book Chart

HLB Science Annual Data

Trend

Dec22

Dec23

Price-to-Tangible-Book

33.71

HLB Science Quarterly Data

Price-to-Tangible-Book

Competitive Comparison of HLB Science's Price-to-Tangible-Book

For the Biotechnology subindustry, HLB Science's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HLB Science's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Science's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where HLB Science's Price-to-Tangible-Book falls into.

HLB Science Price-to-Tangible-Book Calculation

HLB Science's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: . 20 )
	=	2075.00	/
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

HLB Science Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of HLB Science's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Science (XKRX:343090) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR

Website

http://www.hlbscience.com

HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines